Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates

Inogen (INGN) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $0.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +27.78%. A quarter ago, it was expected that this produces oxygen concentrators for patients suffering from chronic respiratory conditions would post a loss of $0.22 per share when it actually produced a loss of $0.2, delivering ...